Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)
Clinical trial NCT02674009 · COMPLETED
Trial details
- NCT number
- NCT02674009
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-09-17
- Primary completion
- 2019-03-31
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.